Search Page

1

Cite

Share

Cavernous Sinus Involvement by Pituitary Adenomas: Clinical Implications and Outcomes of Endoscopic Endonasal Resection.

Ajlan A, Achrol AS, Albakr A, Feroze AH, Westbroek EM, Hwang P, Harsh GR 4th. Ajlan A, et al. J Neurol Surg B Skull Base. 2017 Jun;78(3):273-282. doi: 10.1055/s-0036-1598022. Epub 2017 Jan 23. J Neurol Surg B Skull Base. 2017. PMID: 28603683 Free PMC article.

Cite

Share

2

Cite

Share

Temozolomide-Induced Shrinkage of Invasive Pituitary Adenoma in Patient with Nelson's Syndrome: A Case Report and Review of the Literature.

Kurowska M, Nowakowski A, Zieliński G, Malicka J, Tarach JS, Maksymowicz M, Denew P. Kurowska M, et al. Case Rep Endocrinol. 2015;2015:623092. doi: 10.1155/2015/623092. Epub 2015 Jun 29. Case Rep Endocrinol. 2015. PMID: 26221547 Free PMC article.

Cite

Share

3

Cite

Share

Prognostic factors of regrowth in nonfunctioning pituitary tumors.

Raverot G, Vasiljevic A, Jouanneau E. Raverot G, et al. Pituitary. 2018 Apr;21(2):176-182. doi: 10.1007/s11102-017-0861-3. Pituitary. 2018. PMID: 29288467 Review.

Cite

Share

4

Cite

Share

Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline.

Astaf'eva L, Shishkina L, Kalinin P, Kadashev B, Melnichenko G, Tserkovnay D, Sharipov O. Astaf'eva L, et al. Asian J Neurosurg. 2020 May 29;15(2):385-390. doi: 10.4103/ajns.AJNS_16_20. eCollection 2020 Apr-Jun. Asian J Neurosurg. 2020. PMID: 32656137 Free PMC article.

Cite

Share

5

Cite

Share

Genetically engineered mouse models of pituitary tumors.

Cano DA, Soto-Moreno A, Leal-Cerro A. Cano DA, et al. Front Oncol. 2014 Aug 1;4:203. doi: 10.3389/fonc.2014.00203. eCollection 2014. Front Oncol. 2014. PMID: 25136513 Free PMC article. Review.

Cite

Share

6

Cite

Share

The Past, Present, and Future Statuses of Formerly Classified "Atypical Pituitary Adenomas": A Clinicopathological Assessment of 101 Cases in a Cohort of More than 1,000 Pure Endoscopically Treated Patients in Single Center.

Bal E, Kulaç İ, Ayhan S, Söylemezoğlu F, Berker M. Bal E, et al. J Neurol Surg B Skull Base. 2021 Jul;82(Suppl 3):e94-e100. doi: 10.1055/s-0040-1702219. Epub 2020 Feb 20. J Neurol Surg B Skull Base. 2021. PMID: 34306922 Free PMC article.

Cite

Share

7

Cite

Share

Marked Response of a Hypermutated ACTH-Secreting Pituitary Carcinoma to Ipilimumab and Nivolumab.

Lin AL, Jonsson P, Tabar V, Yang TJ, Cuaron J, Beal K, Cohen M, Postow M, Rosenblum M, Shia J, DeAngelis LM, Taylor BS, Young RJ, Geer EB. Lin AL, et al. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3925-3930. doi: 10.1210/jc.2018-01347. J Clin Endocrinol Metab. 2018. PMID: 30085142 Free PMC article.

Cite

Share

8

Cite

Share

Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.

Lu JQ, Adam B, Jack AS, Lam A, Broad RW, Chik CL. Lu JQ, et al. Endocr Pathol. 2015 Sep;26(3):263-72. doi: 10.1007/s12022-015-9383-6. Endocr Pathol. 2015. PMID: 26187094

Cite

Share

9

Cite

Share

Management of large aggressive nonfunctional pituitary tumors: experimental medical options when surgery and radiation fail.

Miller BA, Rutledge WC, Ioachimescu AG, Oyesiku NM. Miller BA, et al. Neurosurg Clin N Am. 2012 Oct;23(4):587-94. doi: 10.1016/j.nec.2012.06.013. Neurosurg Clin N Am. 2012. PMID: 23040745

Cite

Share

10

Cite

Share

Invasive adenoma and pituitary carcinoma: a SEER database analysis.

Hansen TM, Batra S, Lim M, Gallia GL, Burger PC, Salvatori R, Wand G, Quinones-Hinojosa A, Kleinberg L, Redmond KJ. Hansen TM, et al. Neurosurg Rev. 2014 Apr;37(2):279-85; discussion 285-6. doi: 10.1007/s10143-014-0525-y. Epub 2014 Feb 14. Neurosurg Rev. 2014. PMID: 24526366 Free PMC article.

Cite

Share